DMVeille DM

Field safety notices: Saladax Biomedical Inc.

Manufacturer registered in EUDAMED: SRN US-MF-000007957 ; country: United States

3 authority publications by 2 authorities, from 28 Feb 2020 to 31 Aug 2026.

Latest notice: 31 Aug 2026, MHRA, MyCare Insite Total Aripiprazole Test

Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Saladax Biomedical Inc. or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.

2 distinct corrective actions.

  1. MyCare Insite Total Aripiprazole Test

    Source: MHRA, Field Safety Notices, gov.uk (Open Government Licence v3.0) Contains public sector information licensed under the Open Government Licence v3.0. · collected 16 Nov 2026

Corrective action: 2 publications by AEMPS, from 28 Feb 2020 to 5 Mar 2020

  1. MyCare Insite Clozapine Test. Referencia: CLZ-MCI

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

  2. MyCare Insite Clozapine Test. Referencia: CLZ-MCI

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

The authorities that published these notices